The overexpression of BLT1 (the receptor of leukotriene B4, an AA metabolite via lipoxygenase pathway) is detected in human CRC tissue, while U75302, a selective BLT1 antagonist, can increase the apoptosis and decrease the proliferation of colon cancer cells [64]. Here, LTB4R is linked to malignant colon neoplasm.